Association between adipophilin expression and risk of dyslipidaemia in patients with granuloma annulare

Med Clin (Barc). 2024 Sep 13;163(5):232-237. doi: 10.1016/j.medcli.2024.01.015. Epub 2024 Jun 9.
[Article in English, Spanish]

Abstract

Background: An association between granuloma annulare (GA) and dyslipidaemia has been reported. Adipophilin expression may play a plausible role as a cutaneous biomarker for dyslipidaemia in patients with GA; however, this potential link remains to be explored.

Methods: Patients with GA were identified at our hospital between January 1, 1990, and December 31, 2021, with a thorough review of their clinical and histological characteristics. Adipophilin staining was assessed in biopsies of GA lesions.

Results: A total of 107 patients with GA were included. The prevalence of dyslipidaemia in patients with positive adipophilin staining was clearly higher than in those with negative labelling (62.3% vs 13.3%). Relative to the dyslipidaemia risk for patients with negative adipophilin expression, the odds for patients with positive adipophilin expression were increased 10-fold (OR: 10.8; p-value<.01). We identified 23 incident cases of dyslipidaemia over a median follow-up period of 91 months among 54 patients with no history of dyslipidaemia. The patients with positive adipophilin expression showed a higher risk of developing dyslipidaemia (HR: 8.9; p-value<.01).

Conclusions: Patients with positive adipophilin staining in their GA biopsies were found to be associated with a higher risk for both baseline and incident dyslipidaemia.

Keywords: Biomarcador; Biomarker; Dislipemia; Dyslipidemia; Enfermedad metabólica; Granuloma annulare; Granuloma anular; Metabolic disease.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / metabolism
  • Biopsy
  • Dyslipidemias* / complications
  • Dyslipidemias* / metabolism
  • Female
  • Granuloma Annulare* / metabolism
  • Humans
  • Male
  • Middle Aged
  • Perilipin-2* / analysis
  • Perilipin-2* / metabolism
  • Retrospective Studies
  • Risk Factors

Substances

  • Perilipin-2
  • PLIN2 protein, human
  • Biomarkers